After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Yahoo Finance discussed the stock recently as it posted Boston Scientific Announces Completion of €2.0 Billion Offering of Senior Notes.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NYSE listed company, BSX falls under the Healthcare sector while operating within the Medical Devices industry segment. The current market capitalization of Boston Scientific Corp. is $98.28B. A total of 4.74 million shares were traded on the day, compared to an average of 6.44M shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, BSX has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 48 BUYs and 36 SELLs from insiders. Insiders purchased 724,713 shares during that period but sold 1,135,824.
In the most recent transaction, Butcher Arthur C sold 9,335 shares of BSX for 67.07 per share on Feb 26. After the transaction, the EVP& Grp Pres, MedSurg & APAC now owns 28,937 company shares. In a previous transaction on Feb 23, Carruthers Wendy sold 6,983 shares at 66.89 per share. BSX shares that EVP, Human Resources owns now total 56,508.
Among the insiders who sold shares, Mirviss Jeffrey B. disposed of 4,960 shares on Feb 21 at a per-share price of $66.35. This resulted in the EVP&Pres, Periph Intervent holding 72,604 shares of BSX after the transaction. In another insider transaction, Brennan Daniel J. sold 13,662 shares at $65.86 per share on Feb 20. Company shares held by the EVP and CFO now total 271,542.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for BSX in the last 3 months, the mean price target is $71.99 with high estimates of $81.00 and low estimates of $63.00. In terms of 52-week highs and lows, BSX has a high of $67.32 and a low of $46.20.
As of this writing, BSX has an earnings estimate of $0.51 per share for the current quarter. EPS was calculated based on a consensus of 25 estimates, with a high estimate of $0.52 per share and a lower estimate of $0.5. The company reported an EPS of $0.5 in the last quarter, which was 4.20% higher than expectations of $0.48.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. BSX’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $9.45B in debt and $4.27B in liabilities at the time. Its Book Value Per Share was $13.16, while its Total Shareholder’s Equity was $16.62B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BSX is Buy with a score of 4.70.
